
Lisocabtagene maraleucel for 2nd line DLBCL: real-world data from the French DESCAR-T registry
During the 2025 ICML meeting, Dr Gabriel Brisou presented French real-world data of DLBCL patients treated with 2nd line liso-cel in the French DESCAR-T registry.